Claude Nicaise – Biography
Last update: February 27, 2026Executive profile
Claude was Senior Vice President, Regulatory and Strategic Management at Alexion Pharmaceuticals, and Vice President of Development, Project Leader at Bristol-Myers Squibb. Claude served as Director at Sarepta Therapeutics.
Claude Nicaise is currentlyChairman of the Board at Cassava Sciences - View - Cassava Sciences org chart
Director at Sarepta Therapeutics - View - Sarepta Therapeutics org chart
Independent Member at Gain Therapeutics - View - Gain Therapeutics org chart
Create your alert
to follow the career of Claude Nicaise.
More about Claude Nicaise
Selected links
Do you need to know more about Claude Nicaise? More results.
Participate
Social media
- Claude Nicaise on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Claude Nicaise
The colleagues of Claude Nicaise
Company Colleagues
- At Cassava Sciences, Claude Nicaise has 15 colleagues including Richard Barry (CEO), Robert Gussin (Director)…
- At Sarepta Therapeutics, Claude Nicaise has 37 colleagues including Douglas Ingram (CEO & Director (leaving)), Michael Chambers (Director)…
- At Gain Therapeutics, Claude Nicaise has 21 colleagues including Gene Mack (CEO & President), Eric Richman (Director)…
Industry Colleagues
- In the Biotechnology industry, Claude Nicaise has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Claude Nicaise.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Claude Nicaise.
